The Company
FishBreed Ltd. ("FishBreed") started to operate in December 2004 as part of MATA technological incubator located at the ROTEM Industrial Park near Dimona.
FishBreed develops therapeutic agents to overcome a broad range of fish reproductive dysfunctions, including failure to initiate the reproductive cycle. In addition, these therapeutic agents can be used to accelerate the onset of puberty, a process by which an immature fish acquires for the first time the capacity to reproduce. Induction of precocious maturation and obtainment of fertilized eggs at a desired time in commercially important fish would:
- Greatly improve the cost-efficiency of finfish farming operations.
- Help introducing new species that are not at hand today for aquaculture purposes.
- Significantly reduce the pressure on fish wild stocks.
The problem
Massive increase in aquaculture production must be based on more productivity of the already commercially used species but not least on the induced reproduction in captivity conditions of potentially suitable new fish species.
Spite of the endocrinologic know-how cumulated during the last 20 years, most of trials to domesticate new species of fish do not succeeded to complete the fish life cycle, due the reduced capability of fish to reproduce in agricultural conditions in captivity.
Market potential
The World Total Market for Aquaculture Fish Production will reach 31.6 million tons in 2008 equivalent to 7.4 billion fish units of averaged weight, 10.9 million parents, and Potential Market amounting $ 163.8 millions - at 10% rate assumption.
Technology (product) Description
FishBreed develops a solution to fish fertility and productivity problems that cause the bottleneck in the process of maturation and reproduction in captivity of fish and prevent their incorporation into the aquaculture.
Aquaculture is the fastest growing animal based food-producing sector, particularly in developing countries. This sector alone contributes nearly a third of the world’s supply of fish products. China and other Asian countries are by far the largest producers.
Applications
Induction of precocious maturation and obtainment of fertilized eggs at a desired time in commercially important fish will:
a) greatly improve the cost-efficiency of finfish farming operations for already commercially used species
b) help introducing new species that are not at hand today for aquaculture purposes
c) significantly reduce the pressure on fish wild stocks.
d) help closing the gap between increased consumption needs and limitations imposed by regulations and treaties on fish wild stocks catch volumes.
Fast growing emerging activities are for instance the farming of Atlantic cod and fattening of wild-caught tuna. While in most countries with aquaculture production about 10 to 20 species are commercially used, there are more than thousand species with potential to be commercially used in aquaculture, the main barrier being the lack of capability to succeed in their (earlier) maturation and massive reproduction in captivity.
Competition
There are no direct competitors to Fishbreed method. Some manufacturers are working in some what obsolete methods like GnRH. These methods do not achieve the required results and the problem of closing life cycle in captivity is still unsolved.
The Team
Mr. Shalom Zemach – CEO, Mr. Zemach has vast experience in Aquaculture development and commercializing.
Dr. Hanna Rozenfeld – CTO, Head of reproduction department of National Center for Mari culture in Eilat, has many years of experience in R&D in that field.
Company Status
The company is engaged with intensive R&D program.
Requirements
Strategic partner
Contact